During Q4, the company billed 11,789 tissue-based units and 12,036 liquid-based units, representing growth of 50% and 10%, respectively.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter